Appiell, a privately-held, early-stage digital health company, today announced topline results of its pilot study showcasing the efficiency and functionality of its artificial intelligence (AI) platform. The study achieved its objectives and confirmed consistency and objectivity in the assessment of rhytids in patients with glabellar frown lines. A validated facial wrinkle scale (FWS) was used for the grade assessment.
Also Read: Lower Named to Fast Company World’s Most Innovative Companies List
Appiell’s unique technology has the potential to be the first comprehensive platform serving the unmet needs of the aesthetics and dermatology community, delivering precision, convenience, and optimal results to the three P’s (patients, practitioners, and product developers). Appiell’s AI platform can potentially allow patients to be in control of their treatment and augment the ability of both the practitioners and product developers to improve outcomes through better care and personalized treatments for their patients.
Key Findings
Consistency: The grading of the GFL patients conducted by the platform was the same at each pass, whereas there was variability between the grading conducted by different physicians (100% for the platform vs. 60% between the physicians). There was also inconsistency between individual physicians’ own grading of the same GFL photos at different passes (78%).
Precision: The study confirmed that the AI Platform was much more sensitive in detecting rhytids and fine lines compared to physicians, in accordance with the validated FWS (100% for the platform vs 67% for the physicians). Availability of real-time data provided potential evidence of accurate onset and duration trend which was deemed anecdotal or speculative previously. In addition, backend data analysis can provide valuable information leading to developing products and marketing strategy specific to patients’ needs.
Convenience: Data collected conveniently, including off hours, minimizes the need for follow-up clinic visits and allows both the patient and their physician to track outcomes and safety remotely. ~80% of the physicians preferred using the AI platform for making assessments and administrative tasks (scheduling, communication, remote monitoring). >87% of the patients preferred the ease of getting wrinkle assessments in real time and ~75% ranked the automated communication as important.
About Appiell
Appiell is a rapidly emerging digital health company founded by seasoned executives from technology and aesthetics backgrounds, with proven success at companies like Oracle,